 | Up a level |
Delcroix, M., Staehler, G., Ghofrani, H. A., Gruenig, E., Held, M., Halank, M., Klose, H., Noordegraaf, A. Vonk, Rosenkranz, S., Huscher, D., Pittrow, D. and Hoeper, M. (2018). 2015 ERS/ESC Pulmonary Arterial Hypertension Risk Assessment Model Is also Applicable for Patients with Chronic Thromboembolic Pulmonary Hypertension. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970
Klose, H., Gall, H., Ghofrani, H., Gruenig, E., Humbert, M., Simonneau, G., Halank, M., Langleben, D., Snijder, R. J., Escribano, P., Mielniczuk, L. M., Lange, T., Vachiery, J., Wirtz, H., Helmersen, D. S., Tsangaris, I., Barbera, J. A., Pepke-Zaba, J., Boonstra, A., Rosenkranz, S., Ulrich, S., Mascherbauer, R., Delcroix, M., Jansa, P., Gomez Sanchez, M. A., Klotsche, J., Meier, C., Pittrow, D. and Hoeper, M. M. (2018). Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry. Am. J. Respir. Crit. Care Med., 197. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970